Join
Live feed
·
INSIDERFilingvia Quantisnow
Syndax Pharmaceuticals Inc. logo

Chief Financial Officer Goldan Keith A. acquired $10,337 worth of shares (1,219 units at $8.48), was granted 52,250 shares and sold $42,931 worth of shares (2,082 units at $20.62), increasing direct ownership by 56% to 143,839 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SNDX (Syndax Pharmaceuticals Inc.) and more on Quantisnow.